Moderna has another COVID-19 vaccine in its clinical pipeline, which if successful will potentially make distribution and administration easier. The firm already has an mRNA cell-free COVID-19 vaccine, 1273, approved under FDA emergency authorization. However, it is developing an additional COVID-19 vaccine candidate coded 1283, which it believes will be easier to allocate and administrate due to it potentially being refrigerator stable. According to the firm, the next generation COVID-19 vaccine candidate is made from portions of the spike protein,…
